Atlas Trials

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

Clinical trial NCT05123001 · COMPLETED

Trial details

NCT number
NCT05123001
Sponsor
Stanford University
Status
COMPLETED
Study type
OBSERVATIONAL
Hodgkin LymphomaNon Hodgkin LymphomaLeukemiaMultiple Myeloma
Start date
2021-07-15
Primary completion
2022-07-07
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.